4//SEC Filing
Schwartzberg Gil 4
Accession 0001250853-18-000153
CIK 0001335105other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 9:15 PM ET
Size
13.3 KB
Accession
0001250853-18-000153
Insider Transaction Report
Form 4
Schwartzberg Gil
10% Owner
Transactions
- Other
Common Stock
2018-12-07+150,000→ 2,045,068 total - Gift
Warrants to Purchase Common Stock
2018-12-07−1,040,000→ 0 totalExercise: $1.00From: 2018-12-07Exp: 2022-11-30→ Common Stock (1,040,000 underlying) - Gift
Common Stock
2018-12-07−600,000→ 1,066,356 total(indirect: By Trust) - Purchase
Common Stock
2018-12-07$0.50/sh+1,040,000$520,000→ 1,895,068 total - Purchase
Warrants to Purchase Common Stock
2018-12-07$0.50/sh+1,040,000$520,000→ 1,540,000 totalExercise: $1.00From: 2018-12-07Exp: 2022-11-30→ Common Stock (1,040,000 underlying)
Holdings
- 63,811(indirect: By Continuum Partners, L.P.)
Common Stock
Footnotes (3)
- [F1]The reporting person acquired 1,040,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50.
- [F2]Represents shares acquired by the reporting person pursuant to enforcement of a judgment.
- [F3]Represents the reporting person's proportionate interest in Continuum Partners, L.P. which owns 638,115 shares of the issuer's common stock.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001472409
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 9:15 PM ET
- Size
- 13.3 KB